| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $215K | — | +59.0% |
| Cost of Revenue | $25K | — | — |
| R&D Expense | $352K | — | +117.6% |
| SG&A Expense | $775K | — | -12.5% |
| Operating Income | -$956K | — | -1.9% |
| Interest Expense | $31K | — | -64.5% |
| Pre-tax Income | -$860K | — | -1.0% |
| Income Tax | $0 | — | — |
| Net Income | -$831K | — | +1.2% |
| EPS (Diluted) | -$0.03 | — | +50.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $330K | +30.3% | +195.0% |
| Inventory | $143K | +0.0% | +7.4% |
| Current Assets | $1.0M | +25.3% | +80.3% |
| Total Assets | $2.3M | +8.3% | -65.8% |
| Current Liabilities | $8.5M | +2.7% | -36.6% |
| Total Liabilities | $13.9M | +2.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$433K | — | +37.2% |
| Financing Cash Flow | $506K | — | -19.2% |
| -25.0% |
| Stockholders' Equity | -$11.5M | -2.0% | +0.9% |